CRS is the leading worldwide society in the area of controlled release of drugs
María José Alonso’s lab has pioneered numerous discoveries in the field of Nanopharmaceutical Technology and Nanomedicine
This is a new recognition of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine in 2016 and to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE)
Santiago de Compostela, 19 July 2017.- María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been elected President of the Controlled Release Society, Inc. (CRS, Inc), the worldwide leading organization whose goal is to promote and foster delivery sciences and technologies. The nomination and subsequent election was based on her outstanding carrier in drug delivery sciences and technologies as well as on her long-term commitment with the Society.
This is a new recognition of the outstanding career of Professor Alonso by international scientific institutions, after her election to the US National Academy of Medicine in 2016 and to the prestigious College of Fellows of the American Institute for Medical and Biological Engineering’s (AIMBE) in 2017.
Alonso’s research trajectory
María José Alonso’s lab (https://www.usc.gal/grupos/mjalonsolab/) has pioneered numerous discoveries in the field of Nanopharmaceutical Technology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. Currently, she is involved in 7 international projects, 5 of them financed by the European Commission. She is the author of 240 scientific contributions with more than 12,000 cites (H factor 67) and the inventor of 20 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, Thomson Reuters, 2010).
She also serves on the editorial board of 11 journals. In 2006-10, she was the Vice-rector of Research and Innovation of the USC. She has advised the Ministry of Sciences and Innovation in the elaboration of the Law of Sciences, Technology and Innovation, and, she has been part of the advisory council of the Ministry of Health in Spain.
She has received numerous awards, including the ‘King Jaume I Award’ on New Technologies, the ‘Maurice Marie Janot Award’, and the ‘María Josefa Wonenburger Awar’”. She is also a member of three Academies in Spain and the US National Academy of Medicine.
A long commitment with the CRS
María José has also held responsibilities in several scientific societies, among them the CRS. She first contributed to the CRS as the Founder of the Spanish-Portuguese Local Chapter (1994), later as a Governor (1995), as a member of the Board of Scientific Advisors (2012), as a Director-at-Large (2013) and, since 2016, as a Secretary.
Controlled Release Society
The CRS is a global organization whose main goal is “Advancing delivery science and technology to solve global challenges”. In that sense, CRS, the leading worldwide society in this field, gathers delivery scientists, engineers, clinicians, and technical professionals in a multidisciplinary network oriented to broaden the knowledge and the applications of delivery science and technology.
New board
Together with María José Alonso, the other members of the CRS Board of Directors have been also elected. From this moment on, María José Alonso holds the position of President Elect of the Society, and she will hold the full presidency next year. She is the fourth woman elected to the presidency of the CRS in four consecutive elections.
The new Board members were presented this week in Boston, during the 2017 CRS Annual Meeting.
